Argenx-2026_JPM_Conference_Slides_argenx.pdf

1、Leading a new era of innovation in immunology1Forward Looking StatementsThis presentation has been prepared by argenx se(“argenx”or the“company”)for informational purposes only and not for any other purpose.Nothing contained in this presentation is,or should be construed as,a recommendation,promise

2、or representation by the presenter or the company or any director,employee,agent,or adviser of the company.This presentation does not purport to be all-inclusive or to contain all of the information you may desire.Certain information contained in this presentation relates to or is based on studies,p

3、ublications,surveys and other data obtained from third-party sources and the companys own internal estimates and research.While argenx believes these third-party studies,publications,surveys and other data to be reliable as of the date of this presentation,it has not independently verified,and makes

4、 no representation as to the adequacy,fairness,accuracy or completeness of,any information obtained from third-party sources.In addition,no independent source has evaluated the reasonableness or accuracy of argenxs internal estimates or research,and no reliance should be made on any information or s

5、tatements made in this presentation relating to or based on such internal estimates and research.Certain statements contained in this presentation,other than present and historical facts and conditions independently verifiable at the date hereof,may constitute forward-looking statements.These forwar

6、d-looking statements can be identified by the use of forward-looking terminology,including the terms“advance,”“expand,”“future,”“ongoing,”“opportunity,”“potential,”and“will,”and include statements argenx makes regarding its new era of innovation in immunology;its ability to connect science and patie